Literature DB >> 30381850

Cardiac maladaptation in obese pregnant women at term.

B S Buddeberg1, R Sharma2, J M O'Driscoll2,3, A Kaelin Agten4,5, A Khalil4,5, B Thilaganathan4,5.   

Abstract

OBJECTIVE: Obesity is an increasing problem worldwide, with well recognized detrimental effects on cardiovascular health; however, very little is known about the effect of obesity on cardiovascular adaptation to pregnancy. The aim of the present study was to compare biventricular cardiac function at term between obese pregnant women and pregnant women with normal body weight, utilizing conventional echocardiography and speckle-tracking assessment.
METHODS: This was a prospective case-control study of 40 obese, but otherwise healthy, pregnant women with a body mass index (BMI) of ≥ 35 kg/m2 and 40 healthy pregnant women with a BMI of ≤ 30 kg/m2 . All women underwent a comprehensive echocardiographic examination and speckle-tracking assessment at term.
RESULTS: Obese pregnant women, compared with controls, had significantly higher systolic blood pressure (117 vs 109 mmHg; P = 0.002), cardiac output (6.73 vs 4.90 L/min; P < 0.001), left ventricular (LV) mass index (74 vs 64 g/m2 ; P < 0.001) and relative wall thickness (0.43 vs 0.37; P < 0.001). Diastolic dysfunction was present in five (12.5%) controls and 16 (40%) obese women (P = 0.004). In obese women, compared with controls, LV global longitudinal strain (-15.59 vs -17.61%; P < 0.001), LV endocardial (-17.30 vs -19.84%; P < 0.001) and epicardial (-13.10 vs -15.73%; P < 0.001) global longitudinal strain as well as LV early diastolic strain rate (1.05 vs 1.24 /s; P = 0.006) were all significantly reduced. No differences were observed in the degree of LV twist and torsion between the two groups.
CONCLUSIONS: Morbidly obese, but otherwise healthy, pregnant women at term had significant LV hypertrophy with evidence of diastolic dysfunction and impaired deformation indices compared with pregnant women of normal weight. These findings are likely to represent a maladaptive response of the heart to volume overload in obese pregnancy. The impact of theses changes on pregnancy outcome and long-term maternal outcome is unclear.
Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac dysfunction; diastolic dysfunction; echocardiography; obesity; pregnancy; speckle tracking

Mesh:

Year:  2019        PMID: 30381850     DOI: 10.1002/uog.20170

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

1.  Maternal Underweight and Obesity Are Associated with Placental Pathologies in Human Pregnancy.

Authors:  Hailey Scott; David Grynspan; Laura N Anderson; Kristin L Connor
Journal:  Reprod Sci       Date:  2022-06-23       Impact factor: 3.060

2.  Cardiac Remodeling During Pregnancy With Metabolic Syndrome: Prologue of Pathological Remodeling.

Authors:  Yijun Yang; Justin Kurian; Giana Schena; Jaslyn Johnson; Hajime Kubo; Joshua G Travers; Chunya Kang; Anna Maria Lucchese; Deborah M Eaton; Maoting Lv; Na Li; Lorianna G Leynes; Daohai Yu; Fengzhen Yang; Timothy A McKinsey; Raj Kishore; Mohsin Khan; Sadia Mohsin; Steven R Houser
Journal:  Circulation       Date:  2021-02-15       Impact factor: 29.690

3.  Screening Echocardiogram in High-Risk Women with Class III Obesity to Predict the Risk of Preeclampsia.

Authors:  Maeve K Hopkins; Lisa D Levine; Nathanael C Koelper; Celeste Durnwald
Journal:  Am J Perinatol       Date:  2021-11-23       Impact factor: 3.079

4.  Cardiac, renal and uterine hemodynamics changes throughout pregnancy in rats with a prolonged high fat diet from an early age.

Authors:  Lidia Oltra; Virginia Reverte; Antonio Tapia; Juan M Moreno; Francisco J Salazar; María T Llinás
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

5.  Cardiac hypertrophy with obesity is augmented after pregnancy in C57BL/6 mice.

Authors:  Chen Che; Kayla Dudick; Robin Shoemaker
Journal:  Biol Sex Differ       Date:  2019-12-16       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.